Loading...
Loading...
Analysts at BTIG Research initiated coverage on shares of
Histogenics Corporation HSGX with a Buy rating.
The target price for Histogenics is set to $13.
Histogenics' shares closed at $8.43 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
